Pathobiological role of advanced glycation endproducts via mitogen-activated protein kinase dependent pathway in the diabetic vasculopathy

Experimental and Molecular Medicine

Volumn 40, Issue 4, 2008, Pages 398-406

  Yoon, Young Won ^a   Kang, Tae Soo ^c   Lee, Byoung Kwon ^d   Chang, Woochul ^b   Hwang, Ki Chul ^b   Rhee, Ji Hyuck ^a   Min, Pil Ki ^a   Hong, Bum Kee ^a   Rim, Se Joong ^a   Kwon, Hyuck Moon ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Dankook University   (South Korea)

^d Inje University College of Medicine   (South Korea)

Author keywords

Advanced; Atherosclerosis; Blood vessels; Diabetes mellitus; Glycation end products; Mitogen activated protein kinases

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ARTICLE; ATHEROMA; CELL PROLIFERATION; CONTROLLED STUDY; DIABETIC ANGIOPATHY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN TISSUE; NONHUMAN; PATHOGENESIS; PROTEIN FUNCTION; RAT; RNA INTERFERENCE; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

RATTUS;

EID: 51949117039     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.3858/emm.2008.40.4.398     Document Type: Article

References (31)

1. Bierhaus A, Chevion S, Chevion M, Hofmann M, Quehenberger P, lllmer T, Luther T, Berentshtein E, Tritschler H, Müller M, Wahl P, Ziegler R, Nawroth PP. Advanced glycation endproduct-induced activation of NF-κB is suppressed by alpha-lipoic acid in cultured endothelial cells. Diabetes 1997;46:1481-90
2. Brett J, Schmidt AM, Yan SD, Zou YS, Weidman E, Pinsky D, Nowygrod R, Neeper M, Przysiecki C, Shaw A. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am J Pathol 1993;143:1699-712
3. Brownlee M, Cerami A, Vlassara H. AGEs in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988;318:1315-21
4. Brownlee M. Advanced glycosylation in diabetes and aging. Ann Rev Med 1995;46:223-34
5. Chappey O, Dosquet C, Wautier MP, Wautier JL. Advanced glycation end products, oxidant stress and vascular lesions. Eur J Clin Invest 1997;27:97-108
6. Choi EY, Kwon HM, Ahn C, Lee GT, Joung B, Hong BK, Yoon YW, Kim D, Byun KH, Kang TS, Yoon SJ, Kwon SW, Lee SJ, Park JK, Kim HS. Serum levels of advanced glycation endproducts are associated with in-stent restenosis in diabetic patients. Yonsei Med J 2005;46:78-85
7. Diabetes Control and Complications Trial (DCCT) Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329: 977-86
8. Higashi T, Sano H, Saishoji T, Ikeda K, Jinnouchi Y, Kanzaki T Morisaki N, Rauvala H, Shichiri M, Horiuchi S. The receptor for advanced glycation end products mediates the chemotaxis of rabbit smooth muscle cells. Diabetes 1997;46: 463-72
9. Huttunen HL, Fages C, Rauvala H. Receptor for advanced glycation endproducts (RAGE)-mediated neurite outgrowth and activation of NF-κB require the cytoplasmic domain of the receptorof but different downstream signaling pathways. J Biol Chem 1999;274:19919-24
10. Hwang KC, Lee KH, Jang Y Inhibition of MEK1,2/ERK mitogenic pathway by estrogen with antiproliterative properties in rat aortic smooth muscle cells. J Steroid Biochem Mol Biol 2002;80:85-90
11. Indolfi C, Torella D, Cavuto L, Davalli AM, Coppola C, Esposito G, Carriero MV, Rapacciuolo A, Di Lorenzo E, Stabile E, Perrino C, Chieffo A, Pardo F, Chiariello M. Effects of balloon injury on neointimal hyperplasia in streptozocin-induced diabetes and in hyperinsulinemic nondiabetic pancreatic islet transplanted rats. Circulation 2001;103: 2980-6
12. Kannel WB, McGee DL. Diabetes and cardiovascular disease: The Framingham Study. J Am Med Assoc 1979; 241:2035-38
13. King G, Brownlee M. The cellular and molecular mechanisms of diabetic complications. Endocrinol Metab Clin North Am 1996;25:255-70
14. Kornowski R, Hong MK, Tio FO, Bramwell O, Wu H, Leon MB. In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 1998;31:224-30
15. Lander HM, Tauras JM, Ogiste JS, Hori O, Moss RA, Schmidt AM. Activation of the receptor for advanced glycation endproducts triggers a p21 (ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J Biol Chem 1997;272:17810-4
16. Lee BH, Bae JS, Park RW, Kim JE, Park JY, Kim IS. Big-h3 triggers signaling pathways mediating adhesion and migration of vascular smooth muscle cells through αvβ5 integrin. Exp Mol Med 2006;38:153-61
17. Lee KH, Lim S, Kang SM, Kim DH, Cho HK, Chung JH, Kwon HM, Chung H, Lee H, Jang Y, Hwang KC. Antiproliferative mechanisms of raxofelast (IRFI-016) in H202-stimulated rat aortic smooth muscle cells. Eur J Pharmacol 2004;484: 119-25
18. Li JH, Huang XR, Zhu H, Oldfield M, Cooper M, Truong LD, Johnson RJ, Lan HY Advanced glycation end products activate Smad signaling via TGF-β-dependent and-independent mechanisms: implications for diabetic renal and vascular disease. FASEB J 2004;18:176-8
19. Li SY, Sigmon VK, Babcock SA, Ren J. Advanced glycation endproduct induced ROS accumulation, apoptosis, MAP kinase activation and nuclear O-GlcNAcylation in human cardiac myocytes. Life Sci 2007;80:1051-6
20. Miyata T, Hori O, Zhang J, Yan SD, Ferran L, lida Y, Schmidt AM. The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGR-β2 microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway: implications for the pathogenesis of dialysis-related amyloidosis. J Clin Invest 1996; 98:1088-94
21. Ritthaler U, Deng Y, Zhang Y, Greten J, Abel M, Sido B, Allenberg J, Otto G, Roth H, Bierhaus A, Ziegler R, Schmidt AM, Waldherr R, Wahl R Stern DM, Nawroth PP. Expression of RAGE in peripheral occlusive vascular disease. Am J Pathol 1995;146:688-94
22. Sakaguchi T, Yan SF, Yan SD, Belov D, Rong LL, Sousa M, Andrassy M, Marso SP, Duda S, Arnold B, Liliensiek B, Nawroth PP, Stern DM, Schmidt AM, Naka Y Central role of RAGE-dependent neointimal expansion in arterial restenosis. J Clin Invest 2003;111:959-72
23. Stephenson K, Tunstead J, Tsai A, Gordon R, Henderson S, Dansky HM. Neointimal formation after endovascular arterial injury is markedly attenuated in db/db mice Arterioscler Thromb Vasc Biol 2003;23:2027-33
24. Uusitupa Ml, Niskanen LK, Siitonen O, Voutilainen E, Pyorala K. Five-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and non-diabetic subjects. Circulation 1990;82:27-36
25. Van Belle E, Bauters C, Hubert E, Bodart JC, Abolmaali K, Meurice T, McFadden EP, Lablanche JM, Bertrand ME. Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary arteries. Circulation 1997;96:1454-60
26. Vlassara H, Bucala R, Striker LJ. Pathogenic effects of advanced glycation: Biochemical, biological, and clinical implications for diabetes and aging. Lab Invest 1994;70: 138-51
27. Wautier MP, Chappey O, Corda S, Stern DM, Schmidt AM, Wautier JL. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol Endocrinol Metab 2001;280:685-94
28. West NE, Ruygrok PN, Disco CM, Webster MW, Lindeboom WK, O'Neill WW, Mercado NF, Serruys PW. Clinical and angiographic predictors of restenosis after stent deployment in diabetic patients. Circulation 2004;109:867-73
29. Won SM, Park YH, Kim HJ, Park KM, Lee WJ. Catechins inhibits angiotensin ll-induced vascular smooth muscle cell proliferation via mitogen-associated protein kinase pathway. Exp Mol Med 2006;38:525-34
30. Yamamoto Y, Yamagishi S, Hsu CC, Yamamoto H. Advanced glycation end products-receptor interactions stimulate the growth of human pancreatic cancer cells through the induction of platelet-derived growth factor-B. Biochem Biophys Res Commun 1996;222:700-5
31. Zhou Z, Wang K, Penn MS, Marso SP, Lauer MA, Forudi F, Zhou X, Qu W, Lu Y, Stern DM, Schmidt AM, Lincoff AM, Topol EJ. Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury. Circulation 2003; 107: 2238-43